Congress Park Capital’s Gilead Sciences GILD Stock Holding History

Congress Park Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$281K	Buy	2,225 +700	+46%	+$92.2K	0.08%	110
2026 Q1	$213K	Buy	+1,525	New	+$214K	0.07%	125
2022 Q1	–	Sell	-3,250	Closed	-$236K	–	147
2021 Q4	$236K	Hold	3,250	–	–	0.12%	125
2021 Q3	$227K	Hold	3,250	–	–	0.12%	120
2021 Q2	$224K	Hold	3,250	–	–	0.11%	121
2021 Q1	$210K	Buy	+3,250	New	+$210K	0.12%	120
2020 Q1	–	Sell	-3,500	Closed	-$227K	–	91
2019 Q4	$227K	Hold	3,500	–	–	0.17%	88
2019 Q3	$222K	Hold	3,500	–	–	0.19%	80
2019 Q2	$234K	Hold	3,500	–	–	0.19%	85
2019 Q1	$228K	Sell	3,500 -200	-5%	-$13.3K	0.2%	84
2018 Q4	$231K	Hold	3,700	–	–	0.25%	77
2018 Q3	$286K	Hold	3,700	–	–	0.26%	86
2018 Q2	$262K	Hold	3,700	–	–	0.25%	85
2018 Q1	$279K	Sell	3,700 -1,875	-34%	-$149K	0.29%	78
2017 Q4	$399K	Buy	+5,575	New	+$423K	0.4%	68

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Congress Park Capital's GILD Position: Q2 2026 in Review

Congress Park Capital increased its Gilead Sciences (GILD) stake by 46% in Q2 2026, buying an estimated $92.2K and bringing the position to 2,225 shares worth $281K. The position accounts for 0.08% of the portfolio, ranked #110.

Congress Park Capital first reported a position in GILD in Q4 2017 and has held it in 15 quarters since. The position peaked at $399K in Q4 2017. 999 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Congress Park Capital held 2,225 shares of Gilead Sciences worth $281K as of Q2 2026.
Congress Park Capital bought 700 Gilead Sciences shares in Q2 2026, an estimated $92.2K.
Gilead Sciences made up 0.08% of Congress Park Capital's portfolio in Q2 2026, its #110 holding.
Congress Park Capital first reported a position in Gilead Sciences in Q4 2017 and has held it in 15 quarters since.
Congress Park Capital's Gilead Sciences position peaked at $399K in Q4 2017.
999 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Congress Park Capital's 13F filing for Q2 2026, filed 14 Jul 2026.